Corbus Pharmaceuticals Holdings (CRBP) estimated to achieve -32.90% EPS growth for this year Wallstreet Investorplace
Valuation-related measures are often lousy instruments for timing the market. But that doesn’t mean they can’t hold interesting information about equity market …